NVAX logo

Novavax (NVAX) Operating Profit

Annual Operating Profit

-$566.51 M
+$78.22 M+12.13%

December 31, 2023


Summary


Performance

NVAX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXprofitabilitymetrics:

Quarterly Operating Profit

-$134.02 M
-$295.02 M-183.24%

September 30, 2024


Summary


Performance

NVAX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXprofitabilitymetrics:

TTM Operating Profit

-$301.42 M
-$8.39 M-2.86%

September 30, 2024


Summary


Performance

NVAX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NVAX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.1%-6.7%+51.9%
3 y3 years-36.0%+83.8%+82.1%
5 y5 years-225.7%-485.3%-168.5%

NVAX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+66.4%-164.0%+83.8%-2.9%+82.1%
5 y5-year-337.1%+66.4%-164.0%+83.8%-225.4%+82.1%
alltimeall time<-9999.0%+66.4%-164.0%+83.8%<-9999.0%+82.1%

Novavax Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$134.02 M(-183.2%)
-$301.42 M(+2.9%)
Jun 2024
-
$161.00 M(-211.2%)
-$293.03 M(-26.5%)
Mar 2024
-
-$144.83 M(-21.1%)
-$398.57 M(-29.6%)
Dec 2023
-$566.51 M(-12.1%)
-$183.57 M(+46.1%)
-$566.51 M(-9.6%)
Sep 2023
-
-$125.63 M(-326.5%)
-$626.82 M(-0.2%)
Jun 2023
-
$55.46 M(-117.7%)
-$628.38 M(-46.1%)
Mar 2023
-
-$312.77 M(+28.2%)
-$1.17 B(+81.0%)
Dec 2022
-$644.74 M(-61.8%)
-$243.88 M(+91.7%)
-$644.74 M(-47.4%)
Sep 2022
-
-$127.19 M(-73.7%)
-$1.23 B(-12.8%)
Jun 2022
-
-$482.96 M(-330.8%)
-$1.41 B(+10.8%)
Mar 2022
-
$209.29 M(-125.4%)
-$1.27 B(-24.8%)
Dec 2021
-$1.69 B(+304.7%)
-$824.97 M(+168.6%)
-$1.69 B(+61.5%)
Sep 2021
-
-$307.14 M(-11.2%)
-$1.04 B(+12.2%)
Jun 2021
-
-$345.83 M(+65.8%)
-$931.26 M(+54.6%)
Mar 2021
-
-$208.63 M(+14.1%)
-$602.45 M(+44.6%)
Dec 2020
-$416.72 M(+221.5%)
-$182.85 M(-5.7%)
-$416.72 M(+58.7%)
Sep 2020
-
-$193.94 M(+1039.0%)
-$262.57 M(+183.5%)
Jun 2020
-
-$17.03 M(-25.6%)
-$92.63 M(-17.5%)
Mar 2020
-
-$22.90 M(-20.2%)
-$112.27 M(-13.4%)
Dec 2019
-$129.60 M(-25.5%)
-$28.70 M(+19.6%)
-$129.60 M(-12.1%)
Sep 2019
-
-$24.00 M(-34.5%)
-$147.40 M(-10.8%)
Jun 2019
-
-$36.67 M(-8.8%)
-$165.30 M(-3.1%)
Mar 2019
-
-$40.22 M(-13.5%)
-$170.63 M(-1.9%)
Dec 2018
-$173.92 M(+1.3%)
-$46.51 M(+11.0%)
-$173.92 M(-0.7%)
Sep 2018
-
-$41.90 M(-0.2%)
-$175.19 M(+0.2%)
Jun 2018
-
-$41.99 M(-3.5%)
-$174.92 M(+0.3%)
Mar 2018
-
-$43.51 M(-8.9%)
-$174.40 M(+1.6%)
Dec 2017
-$171.71 M(-36.2%)
-$47.78 M(+14.8%)
-$171.71 M(-3.5%)
Sep 2017
-
-$41.63 M(+0.4%)
-$177.97 M(-10.9%)
Jun 2017
-
-$41.47 M(+1.6%)
-$199.65 M(-14.9%)
Mar 2017
-
-$40.83 M(-24.5%)
-$234.68 M(-12.8%)
Dec 2016
-$269.11 M(+71.2%)
-$54.05 M(-14.6%)
-$269.11 M(-8.5%)
Sep 2016
-
-$63.31 M(-17.2%)
-$293.97 M(+11.4%)
Jun 2016
-
-$76.50 M(+1.6%)
-$263.86 M(+26.7%)
Mar 2016
-
-$75.26 M(-4.6%)
-$208.18 M(+32.4%)
Dec 2015
-$157.24 M(+87.9%)
-$78.90 M(+137.7%)
-$157.24 M(+42.9%)
Sep 2015
-
-$33.20 M(+59.4%)
-$110.00 M(+13.9%)
Jun 2015
-
-$20.82 M(-14.4%)
-$96.59 M(+3.2%)
Mar 2015
-
-$24.31 M(-23.2%)
-$93.62 M(+11.9%)
Dec 2014
-$83.69 M(+59.6%)
-$31.66 M(+60.0%)
-$83.69 M(+26.3%)
Sep 2014
-
-$19.79 M(+10.9%)
-$66.28 M(+7.3%)
Jun 2014
-
-$17.85 M(+24.1%)
-$61.77 M(+8.7%)
Mar 2014
-
-$14.38 M(+0.9%)
-$56.81 M(+8.4%)
Dec 2013
-$52.43 M(+76.8%)
-$14.25 M(-6.7%)
-$52.44 M(+10.0%)
Sep 2013
-
-$15.28 M(+18.5%)
-$47.68 M(+21.5%)
Jun 2013
-
-$12.90 M(+28.9%)
-$39.25 M(+21.9%)
Mar 2013
-
-$10.01 M(+5.4%)
-$32.20 M(+8.6%)
Dec 2012
-$29.66 M(+37.5%)
-$9.49 M(+38.6%)
-$29.67 M(+21.4%)
Sep 2012
-
-$6.85 M(+17.0%)
-$24.43 M(+13.4%)
Jun 2012
-
-$5.86 M(-21.6%)
-$21.55 M(-0.3%)
Mar 2012
-
-$7.47 M(+75.3%)
-$21.61 M(+0.2%)
Dec 2011
-$21.58 M(-43.9%)
-$4.26 M(+7.3%)
-$21.58 M(-11.4%)
Sep 2011
-
-$3.97 M(-33.0%)
-$24.35 M(-21.3%)
Jun 2011
-
-$5.92 M(-20.3%)
-$30.92 M(-10.3%)
Mar 2011
-
-$7.43 M(+5.7%)
-$34.47 M(-10.5%)
Dec 2010
-$38.49 M
-$7.03 M(-33.3%)
-$38.49 M(-15.6%)
Sep 2010
-
-$10.54 M(+11.3%)
-$45.62 M(+5.3%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$9.47 M(-17.3%)
-$43.34 M(+3.9%)
Mar 2010
-
-$11.45 M(-19.1%)
-$41.70 M(+11.5%)
Dec 2009
-$37.38 M(+8.8%)
-$14.15 M(+71.3%)
-$37.38 M(+15.2%)
Sep 2009
-
-$8.26 M(+5.5%)
-$32.44 M(-4.3%)
Jun 2009
-
-$7.83 M(+9.7%)
-$33.90 M(-1.1%)
Mar 2009
-
-$7.14 M(-22.5%)
-$34.28 M(-0.2%)
Dec 2008
-$34.36 M(+13.5%)
-$9.21 M(-5.3%)
-$34.36 M(+20.8%)
Sep 2008
-
-$9.73 M(+18.6%)
-$28.45 M(+1.7%)
Jun 2008
-
-$8.20 M(+13.6%)
-$27.98 M(-1.8%)
Mar 2008
-
-$7.22 M(+119.1%)
-$28.50 M(-2.1%)
Dec 2007
-$30.27 M(+43.4%)
-$3.30 M(-64.4%)
-$29.12 M(-0.2%)
Sep 2007
-
-$9.26 M(+6.1%)
-$29.17 M(+13.9%)
Jun 2007
-
-$8.72 M(+11.3%)
-$25.61 M(+7.1%)
Mar 2007
-
-$7.84 M(+134.1%)
-$23.92 M(+13.3%)
Dec 2006
-$21.12 M(+389.2%)
-$3.35 M(-41.2%)
-$21.12 M(+240.4%)
Sep 2006
-
-$5.69 M(-19.1%)
-$6.20 M(+125.8%)
Jun 2006
-
-$7.04 M(+39.8%)
-$2.75 M(+194.1%)
Mar 2006
-
-$5.04 M(-143.5%)
-$934.00 K(-78.4%)
Dec 2005
-$4.32 M(-82.4%)
$11.56 M(-616.9%)
-$4.32 M(-83.3%)
Sep 2005
-
-$2.24 M(-57.2%)
-$25.79 M(-0.3%)
Jun 2005
-
-$5.22 M(-37.9%)
-$25.87 M(-7.6%)
Mar 2005
-
-$8.42 M(-15.0%)
-$27.98 M(+14.4%)
Dec 2004
-$24.46 M(+52.4%)
-$9.91 M(+327.1%)
-$24.46 M(+38.9%)
Sep 2004
-
-$2.32 M(-68.4%)
-$17.62 M(-3.5%)
Jun 2004
-
-$7.34 M(+49.9%)
-$18.26 M(+17.4%)
Mar 2004
-
-$4.90 M(+60.0%)
-$15.55 M(-3.1%)
Dec 2003
-$16.05 M(-25.5%)
-$3.06 M(+3.4%)
-$16.05 M(-6.0%)
Sep 2003
-
-$2.96 M(-36.1%)
-$17.09 M(-17.1%)
Jun 2003
-
-$4.63 M(-14.2%)
-$20.60 M(-4.1%)
Mar 2003
-
-$5.40 M(+32.0%)
-$21.49 M(-0.3%)
Dec 2002
-$21.56 M(+132.9%)
-$4.09 M(-36.8%)
-$21.56 M(+5.1%)
Sep 2002
-
-$6.48 M(+17.5%)
-$20.52 M(+25.0%)
Jun 2002
-
-$5.51 M(+0.7%)
-$16.41 M(+30.5%)
Mar 2002
-
-$5.47 M(+79.6%)
-$12.58 M(+35.9%)
Dec 2001
-$9.26 M(-27.4%)
-$3.05 M(+28.5%)
-$9.26 M(-18.0%)
Sep 2001
-
-$2.37 M(+41.0%)
-$11.29 M(-8.2%)
Jun 2001
-
-$1.68 M(-21.9%)
-$12.29 M(-8.5%)
Mar 2001
-
-$2.15 M(-57.7%)
-$13.44 M(+5.5%)
Dec 2000
-$12.74 M(+177.0%)
-$5.08 M(+50.6%)
-$12.74 M(+45.5%)
Sep 2000
-
-$3.38 M(+19.4%)
-$8.76 M(+21.9%)
Jun 2000
-
-$2.83 M(+94.3%)
-$7.18 M(+39.3%)
Mar 2000
-
-$1.46 M(+32.3%)
-$5.16 M(+12.1%)
Dec 1999
-$4.60 M(-11.5%)
-$1.10 M(-38.9%)
-$4.60 M(-11.5%)
Sep 1999
-
-$1.80 M(+125.0%)
-$5.20 M(+10.6%)
Jun 1999
-
-$800.00 K(-11.1%)
-$4.70 M(-9.6%)
Mar 1999
-
-$900.00 K(-47.1%)
-$5.20 M(0.0%)
Dec 1998
-$5.20 M(+8.3%)
-$1.70 M(+30.8%)
-$5.20 M(+13.0%)
Sep 1998
-
-$1.30 M(0.0%)
-$4.60 M(+2.2%)
Jun 1998
-
-$1.30 M(+44.4%)
-$4.50 M(0.0%)
Mar 1998
-
-$900.00 K(-18.2%)
-$4.50 M(-4.3%)
Dec 1997
-$4.80 M(-12.7%)
-$1.10 M(-8.3%)
-$4.70 M(-13.0%)
Sep 1997
-
-$1.20 M(-7.7%)
-$5.40 M(+3.8%)
Jun 1997
-
-$1.30 M(+18.2%)
-$5.20 M(0.0%)
Mar 1997
-
-$1.10 M(-38.9%)
-$5.20 M(0.0%)
Dec 1996
-$5.50 M
-$1.80 M(+80.0%)
-$5.20 M(+52.9%)
Sep 1996
-
-$1.00 M(-23.1%)
-$3.40 M(+41.7%)
Jun 1996
-
-$1.30 M(+18.2%)
-$2.40 M(+118.2%)
Mar 1996
-
-$1.10 M
-$1.10 M

FAQ

  • What is Novavax annual operating income?
  • What is the all time high annual operating profit for Novavax?
  • What is Novavax annual operating profit year-on-year change?
  • What is Novavax quarterly operating income?
  • What is the all time high quarterly operating profit for Novavax?
  • What is Novavax quarterly operating profit year-on-year change?
  • What is Novavax TTM operating income?
  • What is the all time high TTM operating profit for Novavax?
  • What is Novavax TTM operating profit year-on-year change?

What is Novavax annual operating income?

The current annual operating profit of NVAX is -$566.51 M

What is the all time high annual operating profit for Novavax?

Novavax all-time high annual operating income is -$4.32 M

What is Novavax annual operating profit year-on-year change?

Over the past year, NVAX annual operating income has changed by +$78.22 M (+12.13%)

What is Novavax quarterly operating income?

The current quarterly operating profit of NVAX is -$134.02 M

What is the all time high quarterly operating profit for Novavax?

Novavax all-time high quarterly operating income is $209.29 M

What is Novavax quarterly operating profit year-on-year change?

Over the past year, NVAX quarterly operating income has changed by -$8.39 M (-6.68%)

What is Novavax TTM operating income?

The current TTM operating profit of NVAX is -$301.42 M

What is the all time high TTM operating profit for Novavax?

Novavax all-time high TTM operating income is -$934.00 K

What is Novavax TTM operating profit year-on-year change?

Over the past year, NVAX TTM operating income has changed by +$325.40 M (+51.91%)